Report

State of the sector: medical technologies and pharmaceuticals 2017

13 Jul 2017
CREATORS
There is a lot of economic opportunity for Victorian companies to develop and manufacture new drugs, devices and digital health solutions that will shape the future of healthcare.

86

220

Share
APO Collection(s): 
Broad Subject Area(s): 
Geographic Coverage: 

Description

Victoria has one of the world's largest life science clusters composed of the medical technology (medtech), biotechnology (biotech) and pharmaceutical industries. It is home to a vibrant commercial sector, key R&D infrastructure and advanced manufacturing expertise making it a highly sought after destination by global pharmaceutical companies.

The State of the Sector Medical Technologies and Pharmaceuticals 2017 report shows the sector is growing rapidly. The sector employs more than 23,000 people and is made up of more than 650 firms ranging in size from small start-ups to large Victorian exporters and global manufacturers. Revenue in the sector has quadrupled since 2003 to $12.7 billion and exports have doubled since 2011 to $1.3 billion.

With its companies connected to all major international markets, there is a lot of economic opportunity for Victorian companies to develop and manufacture new drugs, devices and digital health solutions that will shape the future of healthcare.

Advertisement

 

PUBLICATION DETAILS

Resource Type: 
Identifiers: 
ISBN
978-1-925629-62-0
Publication Place: 
Melbourne